Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.8.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.54.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LH.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.55.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.53 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.599NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.451NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.313NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.609NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.556NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.245NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.636NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.126NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.31.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used